Impact of Spores on the Comparative Efficacies of Five Antibiotics for Treatment of Bacillus anthracis in anIn VitroHollow Fiber Pharmacodynamic Model

Antibiotics Cure Anthrax in Animal Models

(2011) Shay Weiss et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Differential Effects of Linezolid and Ciprofloxacin on Toxin Production by Bacillus anthracis in anIn VitroPharmacodynamic System

(2011) Arnold Louie et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

The Combination of Meropenem and Levofloxacin Is Synergistic with Respect to both Pseudomonas aeruginosa Kill Rate and Resistance Suppression

(2010) A. Louie et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Impact of Spore Biology on the Rate of Kill and Suppression of Resistance in Bacillus anthracis

(2009) G. L. Drusano et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Antistaphylococcal Agents

(2009) Howard S. Gold et al.   INFECTIOUS DISEASE CLINICS OF NORTH AMERICA

Use of an In Vitro Pharmacodynamic Model To Derive a Linezolid Regimen That Optimizes Bacterial Kill and Prevents Emergence of Resistance in Bacillus anthracis

(2008) A. Louie et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Is 60 Days of Ciprofloxacin Administration Necessary for Postexposure Prophylaxis for Bacillus anthracis?

(2008) G. L. Drusano et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Activities of Clindamycin, Daptomycin, Doxycycline, Linezolid, Trimethoprim-Sulfamethoxazole, and Vancomycin against Community-Associated Methicillin-Resistant Staphylococcus aureus with Inducible Clindamycin Resistance in Murine Thigh Infection and In Vitro Pharmacodynamic Models

(2008) K. L. LaPlante et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY